Zobrazeno 1 - 10
of 10
pro vyhledávání: '"J M, Banus"'
Autor:
J M, Banus Gassol
Publikováno v:
Archivos espanoles de urologia. 66(6)
Autor:
Begoña Bermejo, Antoni Ribas, M. A. Lopez-Pacios, J. M. Banus, Angels Rovirosa, Joaquim Bellmunt, J Carulla, J. A. De Torres, Joan Albanell, Solé La, Joan Morote, R. Vera
Publikováno v:
American journal of clinical oncology. 19(4)
Carboplatin, methotrexate, and vinblastine (M-CAVI) is an active and well-tolerated regimen for bladder cancer patients ineligible for cisplatin-based regimens. We treated 47 T2-4 N0 M0 bladder cancer patients with M-CAVI in a neoadjuvant phase II tr
Publikováno v:
The Journal of urology. 154(2 Pt 1)
Publikováno v:
British journal of urology. 71(4)
Autor:
A, Soler Roselló, J, Conejero Sugrañés, J M, Banus Gassol, A, Prera Vilaseca, A, Ahmad Wahab, J, Vila Barja
Publikováno v:
Archivos espanoles de urologia. 43(4)
Trigono-cervico-prostatotomy (TCP) incision was performed endoscopically in 102 patients, 99 for benign hypertrophy of the prostate (BHP) less than 35 g., and 3 for bladder neck obstruction. Good results were achieved in 81.4%, symptom relief was ach
Publikováno v:
Urologia Internationalis. 43:349-351
We present herewith a case of Wilms' tumor in an adult patient. He underwent radical surgery, chemotherapy (adriamycin, actinomycin, vincristine and cyclophosphamide) and radiotherapy. He is alive and free of disease after 48 months of follow-up.
Publikováno v:
Actas urologicas espanolas. 3(4)
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 7(3)
The fimbriated adhesines constitute a factor of virulence of E. coli in the urinary tract infections. The presence of type 1 fimbriae and fimbriae P was evaluated in 23 E. coli strains isolated with patients with chronic bacterial prostatitis. For th
Publikováno v:
Urologia internationalis. 43(6)
We present herewith a case of Wilms' tumor in an adult patient. He underwent radical surgery, chemotherapy (adriamycin, actinomycin, vincristine and cyclophosphamide) and radiotherapy. He is alive and free of disease after 48 months of follow-up.
Autor:
Eduard Batiste-Alentorn, J. Carles, H. Cortes-Funes, L. Paz-Ares, M. Nogué, J. J. De La Cruz, Marta López-Brea, A. Font, J. Albanell, José Baselga, V. Guillem, Jl Gonzalezlarriba, R. Bastus, Joaquim Bellmunt, Eduard Gallardo, M. A. Climent, A. Saenz, J. M. Banus, Eduardo Díaz-Rubio
Publikováno v:
Scopus-Elsevier
PURPOSE: To determine the maximum-tolerated dose and the antitumor activity of a combination of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma (TCC) of the urothelium. PATIENTS AND METHODS: Patients with measurable, pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9120417a5fe422c47a57c62303bef1e6
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034666030&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034666030&partnerID=MN8TOARS